Mark Eisner
Director/Board Member at The Genentech Foundation
Net worth: 375 805 $ as of 30/03/2024
Profile
Dr. Mark Eisner, MD, is a Chief Medical Officer at FibroGen, Inc. Dr. Eisner was previously employed as a Senior Vice President by Genentech, Inc. and a Professor by The University of California, San Francisco. He received his undergraduate degree from Stanford University, a doctorate degree from UC Berkeley School of Public Health and a doctorate degree from the University of Pennsylvania Medical Center.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
FIBROGEN, INC.
0.16% | 05/09/2023 | 159,917 ( 0.16% ) | 375 805 $ | 30/03/2024 |
Mark Eisner active positions
| Companies | Position | Start |
|---|---|---|
| The Genentech Foundation | Director/Board Member | - |
Former positions of Mark Eisner
| Companies | Position | End |
|---|---|---|
| FIBROGEN, INC. | Chief Tech/Sci/R&D Officer | 07/09/2023 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
| The University of California, San Francisco | Corporate Officer/Principal | - |
Training of Mark Eisner
| Stanford University | Undergraduate Degree |
| UC Berkeley School of Public Health | Doctorate Degree |
| University of Pennsylvania Medical Center | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| FIBROGEN, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| The Genentech Foundation | Miscellaneous |
- Stock Market
- Insiders
- Mark Eisner
